The IN VIVO Blog Podcast: An Interview with Mackay and Dolsten

Oh, do we have a treat for you this week, podcast-listeners, yes we do. Wondering about the new-fangled Pfizer R&D organization that was announced on Tuesday? Tune in to this week's IVB Podcast and hear about it from Pfizer R&D heads Martin Mackay (the small molecule guy) and Mikael Dolsten (the large molecule/vaccines guy), talking to our very own Ellen Licking and Roger Longman. It's the very first time Mackay and Dolsten have granted a joint interview on the impending changes at the bulked up Pfizer.

What's that? You also like to read? Check out the accompanying Pink Sheet Daily story.

Just click the button below to get started. And don't forget, you can access the podcast via iTunes also.